98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12180031 | PMC |
http://dx.doi.org/10.1016/j.jnha.2024.100421 | DOI Listing |
Cancer
July 2025
Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA.
The treatment of peritoneal mesothelioma (PeM) poses significant challenges because of its rare incidence, heterogeneity, and limited clinical evidence. This commentary describes results from a national consensus aimed at addressing the management of PeM. An update of the 2018 Chicago consensus guidelines was conducted with a modified Delphi technique, which encompassed two rounds of voting.
View Article and Find Full Text PDFCancer
July 2025
Cedars-Sinai Medical Center, Los Angeles, California, USA.
Neuroendocrine neoplasms (NENs) with peritoneal metastases (PM) represent a complex clinical challenge because of low incidence and heterogeneous phenotypes. This commentary describes the results of a national consensus aimed at addressing clinical management of patients with NENs and PM. An update of the 2018 Chicago consensus guidelines was conducted with a modified Delphi technique, which encompassed two rounds of voting.
View Article and Find Full Text PDFJ Nutr Health Aging
January 2025
School of Public Health, Faculty of Medicine and Health, Sydney University, Australia. Electronic address:
J Nutr Health Aging
May 2024
Navarrabiomed, Hospital Universitario de Navarra (HUN)-Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain; CIBER of Frailty and Healthy Aging (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
Mol Neurodegener
January 2024
Centro de Biología Molecular Severo Ochoa. Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid (CSIC/UAM), C/ Nicolás Cabrera 1, Campus de Cantoblanco, Madrid, 28049, Spain.